Last Review Performed on: April 10th, 2020

There is not enough evidence to recommend use of this medication for the treatment of COVID-19

Clinical Trials

There is a clinical trial studying IVIg therapeutic agent:

• The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia (NCT04261426)

Peer reviewed articles

There are no major peer-reviewed studies for IVIg use.